Table 2: Indication for procedure.
| All (N = 78) | Men (N = 43) | Women (N = 40) | p-value | |
| Stroke during OAC treatment | 10 (12.8%) | 4 (9.8%) | 6 (16.2%) | 0.935 |
| CVA + previous bleeding | 4 (5.1%) | 2 (4.9%) | 2 (5.4%) | 0.930 |
| Previous bleeding | 57 (73.1%) | 28 (68.3%) | 29 (78.4%) | 0.821 |
| Need for admission | 28 (35.9%) | 15 (36.6%) | 13 (35.1%) | 0.894 |
| Need for transfusion | 21 (26.9%) | 13 (31.7%) | 8 (21.6%) | 0.316 |
| Type of previous bleeding | ||||
| Gastrointestinal bleeding | 33 (42.3%) | 16 (39.0%) | 17 (45.9%) | 0.537 |
| Intracranial hemorrhage | 15 (19.2%) | 8 (19.5%) | 7 (18.9%) | 0.947 |
| Other bleeding | 9 (11.5%) | 4 (9.8%) | 5 (13.5%) | 0.748 |
| Other indications* | 7 (9.0%) | 7 (17.1%) | 0 | 1.000 |
Values are expressed as number (percentage).
CVA: Cerebrovascular accident; Hb: Hemoglobin; OAC: Oral anticoagulant. *High risk of bleeding, poor INR control or patient's decision.